Tapan Kadia Selected Research

Fatigue

9/2019	Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
11/2018	A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tapan Kadia Research Topics

Disease

72	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 08/2010
30	Neoplasms (Cancer) 02/2024 - 08/2011
29	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 01/2012
19	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 01/2010
19	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 06/2014
19	Leukemia 12/2023 - 08/2010
16	Philadelphia Chromosome 01/2022 - 02/2009
8	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 08/2012
8	Residual Neoplasm 01/2021 - 02/2016
7	Acute Promyelocytic Leukemia 02/2024 - 06/2011
7	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 06/2011
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 06/2012
5	Anemia 01/2022 - 08/2009
4	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 07/2012
4	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
4	Exanthema (Rash) 01/2021 - 11/2015
4	Blast Crisis (Blast Phase) 01/2021 - 08/2012
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2012
4	Pathologic Complete Response 09/2019 - 05/2015
3	Lymphoma (Lymphomas) 01/2022 - 06/2012
3	Infections 01/2022 - 11/2015
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Aplastic Anemia (Anemia, Hypoplastic) 11/2022 - 08/2016
2	Leukocytosis (Pleocytosis) 01/2022 - 01/2017
2	Hypertension (High Blood Pressure) 12/2020 - 11/2015
2	Fatigue 09/2019 - 11/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018 - 04/2016
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2017 - 04/2014
2	Nausea 01/2016 - 01/2015
2	Diarrhea 01/2016 - 06/2014
2	Refractory Anemia with Excess of Blasts (RAEM) 10/2014 - 10/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 02/2013 - 07/2012

Drug/Important Bio-Agent (IBA)

18	venetoclaxIBA 04/2024 - 10/2016
16	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 08/2010
15	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 06/2013
15	Tyrosine Kinase InhibitorsIBA 01/2022 - 08/2011
10	Inotuzumab OzogamicinIBA 02/2024 - 03/2015
10	Decitabine FDA Link 01/2022 - 09/2012
8	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 08/2010
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2012
6	Dasatinib (BMS 354825)FDA Link 04/2024 - 08/2011
6	ibrutinibIBA 02/2024 - 01/2019
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2024 - 05/2015
6	Arsenic Trioxide (Trisenox)FDA Link 02/2024 - 05/2015
6	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2022 - 11/2013
6	ruxolitinibIBA 11/2021 - 08/2012
6	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2010
5	blinatumomabIBA 01/2023 - 10/2018
5	fludarabineIBA 01/2023 - 08/2010
5	Sorafenib (BAY 43-9006)FDA Link 11/2020 - 06/2013
5	Clofarabine (Clolar)FDA Link 02/2017 - 09/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 01/2019
4	NivolumabIBA 02/2024 - 01/2019
4	ponatinibIBA 10/2023 - 11/2015
4	Phosphotransferases (Kinase)IBA 01/2023 - 08/2015
4	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 08/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 06/2014
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 12/2012
4	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 05/2015
4	nilotinib FDA Link 11/2016 - 01/2010
3	CreatinineIBA 12/2023 - 01/2022
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 08/2015
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 08/2010
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 02/2017
3	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2015
3	Rituximab (Mabthera)FDA Link 12/2021 - 01/2019
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2019
3	midostaurinIBA 11/2019 - 04/2015
3	Hemoglobins (Hemoglobin)IBA 09/2019 - 09/2014
3	Histone Deacetylase InhibitorsIBA 01/2012 - 08/2010
2	Alkylating AgentsIBA 02/2024 - 06/2012
2	PLX51107IBA 11/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	enasidenibIBA 01/2023 - 01/2022
2	VaccinesIBA 11/2022 - 01/2021
2	MethyltransferasesIBA 01/2021 - 01/2019
2	fms-Like Tyrosine Kinase 3IBA 01/2021 - 08/2012
2	Monoclonal AntibodiesIBA 01/2021 - 03/2015
2	nelarabine (506U78)FDA Link 11/2020 - 01/2018
2	NucleophosminIBA 10/2019 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2018 - 06/2014
2	Janus KinasesIBA 01/2017 - 03/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2016 - 05/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2016 - 05/2015
2	Alanine Transaminase (SGPT)IBA 01/2016 - 11/2015
2	Prednisone (Sone)FDA LinkGeneric 11/2015 - 09/2014
2	Aurora KinasesIBA 08/2015 - 06/2014
2	pomalidomideIBA 09/2014 - 11/2013
2	NucleosidesIBA 06/2014 - 11/2013
2	Vorinostat FDA Link 10/2010 - 08/2010
2	mocetinostatIBA 10/2010 - 08/2010

Therapy/Procedure

60	Therapeutics 03/2024 - 01/2010
33	Drug Therapy (Chemotherapy) 01/2023 - 11/2010
9	Induction Chemotherapy 01/2022 - 08/2010
8	Stem Cell Transplantation 01/2023 - 06/2011
4	Salvage Therapy 01/2023 - 01/2020
3	Radiotherapy 10/2022 - 02/2012
2	Hematopoietic Stem Cell Transplantation 02/2024 - 03/2013
2	Drug Tapering 11/2021 - 11/2020
2	Consolidation Chemotherapy 01/2020 - 01/2018